Zimmer Biomet Holdings (Zimmer Biomet Holdings) Total Liabilities

: $9,009 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

Zimmer Biomet Holdings's Total Liabilities for the quarter that ended in Dec. 2023 was $9,009 Mil.

Zimmer Biomet Holdings's quarterly Total Liabilities declined from Jun. 2023 ($8,915.70 Mil) to Sep. 2023 ($8,699.30 Mil) but then increased from Sep. 2023 ($8,699.30 Mil) to Dec. 2023 ($9,008.80 Mil).

Zimmer Biomet Holdings's annual Total Liabilities declined from Dec. 2021 ($10,790.00 Mil) to Dec. 2022 ($9,039.00 Mil) and declined from Dec. 2022 ($9,039.00 Mil) to Dec. 2023 ($9,008.80 Mil).

Zimmer Biomet Holdings Total Liabilities Historical Data

The historical data trend for Zimmer Biomet Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

12,245.90

12,218.30

10,790.00

9,039.00

9,008.80

Zimmer Biomet Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities																9,039.00	9,085.90	8,915.70	8,699.30	9,008.80

Zimmer Biomet Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zimmer Biomet Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2857.4	+	(5012.6	+	781.2
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	357.6	+	0)
	=	9,009

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	21496.9	-	12488.1
	=	9,009

Zimmer Biomet Holdings's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2857.4	+	(5012.6	+	781.2
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	357.6	+	0)
	=	9,009

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	21496.9	-	12488.1
	=	9,009

Zimmer Biomet Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (NYSE:ZBH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Executives

Syed A. Jafry	director	345 E. MAIN STREET, WARSAW IN 46580
Sreelakshmi Kolli	director	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Christopher B Begley	director
Robert Hagemann	director	3 GIRALDA FARMS, MADISON NJ 07940
Michael W Michelson	director	2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Betsy J Bernard	director	711 HIGH STREET, DES MOINES IA 50392-0300
Arthur J Higgins	director	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Chad F Phipps	officer: Assoc. Gen. Counsel, Corp. Sec	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Zuilen Wilfred Van	officer: Pres, Europe, M. East & Africa	345 E. MAIN STREET, WARSAW IN 46580
Paul A Stellato	officer: VP, Controller & CAO	C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sang Yi	officer: President, Asia Pacific	345 E. MAIN STREET, WARSAW IN 46580
Lori Winkler	officer: SVP and CHRO	345 E. MAIN STREET, WARSAW IN 46580
Rachel Ellingson	officer: SVP & CSO	345 E MAIN STREET, WARSAW K7 46580
Bryan C Hanson	director, officer: President and CEO	ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Aure Bruneau	officer: Group President	345 E. MAIN STREET, WARSAW IN 46580